Stockholders have filed lawsuits against Anywhere over Compass merger disclosures, as lawmakers raise antitrust and market ...
William Blair starts coverage on Compass Therapeutics, saying its lead drug could reshape bile duct cancer treatment and ...
The Compass-Anywhere merger may give one firm over 30% market share in key cities, raising antitrust concerns.
U.S. antitrust enforcers should consider blocking a bid by Compass , the nation's largest residential real estate broker, to acquire rival Anywhere Real Estate , amid a housing shortage, two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback